Press Resease

Pharmacovigilance and Drug Safety Software Market - Global Industry Analysis

Pharmacovigilance and Drug Safety Software Market by Functionality (ADR Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand), and by End-User (Pharma & Biotech Companies, Contract Research Organizations (CROS), Business Process Outsourcing (BPO) Firms, and Other Pharmacovigilance Service Providers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 14-Mar-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3172 Status : Published

Global pharmacovigilance and drug safety software market expected to generate around USD 223 million by 2025, at a CAGR of around 6.7% between 2019 and 2025. Pharmacovigilance and drug safety software or tools aid in classifying, reviewing, and forming pharmacovigilance data. This software also helps in the formation of repots related to adverse medical events.

Description

The report covers a forecast and an analysis of the pharmacovigilance and drug safety software market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the pharmacovigilance and drug safety software market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pharmacovigilance and drug safety software market on a global level.

In order to give the users of this report a comprehensive view of the pharmacovigilance and drug safety software market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Pharmacovigilance and Drug Safety Software Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the pharmacovigilance and drug safety software market by segmenting the market based on functionality, delivery mode, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on functionality, the market is segmented into drug safety audits software, ADR reporting software, fully integrated software, and issue tracking software. By delivery mode, the market is segmented into on-premises and on-demand. By end-user, the market is segmented into contract research organizations (CROS), business process outsourcing (BPO) firms, pharma and biotech companies, and other pharmacovigilance service providers.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global pharmacovigilance and drug safety software market include Oracle Corporation, ArisGlobal LLC, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH, and Ennov Solutions, Inc., among others.

This report segments the global pharmacovigilance and drug safety software market into:

Global Pharmacovigilance and Drug Safety Software Market: Functionality Analysis

  • ADR Reporting Software 
  • Drug Safety Audits Software 
  • Issue Tracking Software 
  • Fully Integrated Software 

Global Pharmacovigilance and Drug Safety Software Market: Delivery Mode Analysis

  • On-Premises
  • On-Demand

Global Pharmacovigilance and Drug Safety Software Market: End-User Analysis

  • Pharma and Biotech Companies
  • Contract Research Organizations (CROS)
  • Business Process Outsourcing (BPO) Firms
  • Other Pharmacovigilance Service Providers 

Global Pharmacovigilance and Drug Safety Software Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Pharmacovigilance and Drug Safety Software Market, 2017-2025 (USD Million)
    • 2.2. Global Pharmacovigilance and Drug Safety Software Market: Snapshot
  •  
  • Chapter 3. Pharmacovigilance and Drug Safety Software Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Pharmacovigilance and Drug Safety Software Market drivers: Impact analysis
      • 3.2.2. The growing rate of clinical trials
      • 3.2.3. An increasing number of CROs
      • 3.2.4. Increasing penetration in emerging countries
    • 3.3. Market Restraints
      • 3.3.1. Global Pharmacovigilance and Drug Safety Software Market restraints: Impact analysis
      • 3.3.2. Stringent Regulations
      • 3.3.3. Concern about drug safety
    • 3.4. Opportunities
      • 3.4.1. Increasing pharma and biotech companies in developing economies
    • 3.5. Porter's Five Forces analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Functionality
      • 3.6.2. Market attractiveness analysis, by Delivery Mode segment
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Pharmacovigilance and Drug Safety Software Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Pharmacovigilance and Drug Safety Software Market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Technology Portfolio
  •  
  • Chapter 5. Global Pharmacovigilance and Drug Safety Software Market - Functionality Analysis
    • 5.1. Global Pharmacovigilance and Drug Safety Software Market: Functionality overview
      • 5.1.1. Global Pharmacovigilance and Drug Safety Software Market revenue share, by Functionality, 2017 and 2025
    • 5.2. ADR Reporting Software
      • 5.2.1. Global ADR Reporting Software Market, 2017-2025 (USD Million)
    • 5.3. Drug Safety Audits Software
      • 5.3.1. Global Drug Safety Audits Software market, 2017-2025 (USD Million)
    • 5.4. Issue Tracking Software
      • 5.4.1. Global Issue Tracking Software market, 2017-2025 (USD Million)
    • 5.5. Fully Integrated Software
      • 5.5.1. Global Fully Integrated Software market, 2017-2025 (USD Million)
  •  
  • Chapter 6. Global Pharmacovigilance and Drug Safety Software Market - Delivery Mode Analysis
    • 6.1. Global Pharmacovigilance and Drug Safety Software Market: Delivery Mode overview
      • 6.1.1. Global Pharmacovigilance and Drug Safety Software Market revenue share, by Delivery Mode, 2017-2025
    • 6.2. On-premises
      • 6.2.1. Global Pharmacovigilance and Drug Safety Software Market for On-premises, 2017-2025 (USD Million)
    • 6.3. On-demand
      • 6.3.1. Global Pharmacovigilance and Drug Safety Software Market for On-demand, 2017-2025 (USD Million)
  •  
  • Chapter 7. Global Pharmacovigilance and Drug Safety Software Market - End-user Analysis
    • 7.1. Global Pharmacovigilance and Drug Safety Software Market: End-user overview
      • 7.1.1. Global Pharmacovigilance and Drug Safety Software Market revenue share, by end-user, 2017and 2025
    • 7.2. Pharma & biotech companies
      • 7.2.1. Global Pharmacovigilance and Drug Safety Software Market for Pharma & biotech companies, 2017-2025 (USD Million)
    • 7.3. Contract Research Organizations (CROS)
      • 7.3.1. Global Pharmacovigilance and Drug Safety Software Market for Contract Research Organizations, 2017-2025 (USD Million)
    • 7.4. Business Process Outsourcing Firms
      • 7.4.1. Global Pharmacovigilance and Drug Safety Software Market for Business Process Outsourcing Firms End-users, 2017-2025 (USD Million)
    • 7.5. Other Pharmacovigilance Service Providers
      • 7.5.1. Global Pharmacovigilance and Drug Safety Software Market for Other End-users, 2017-2025 (USD Million)
  •  
  • Chapter 8. Global Pharmacovigilance and Drug Safety Software Market - Regional Segment Analysis
    • 8.1. Global Pharmacovigilance and Drug Safety Software Market: Regional overview
      • 8.1.1. Global Pharmacovigilance and Drug Safety Software Market revenue share, by region, 2017 and 2025
    • 8.2. North America
      • 8.2.1. North America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.2.2. North America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.2.3. North America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.2.4.2. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.2.4.3. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.2.5.2. Canada Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.2.5.3. Canada Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.3.2. Europe Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.3.3. Europe Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.3.4.2. Germany Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.3.4.3. Germany Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.3.5. France
        • 8.3.5.1. France Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.3.5.2. France Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.3.5.3. France Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.3.6. UK
        • 8.3.6.1. UK Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.3.6.2. UK Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.3.6.3. UK Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.3.7.2. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.3.7.3. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.4.2. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.4.3. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.4.4.2. China Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.4.4.3. China Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.4.5.2. Japan Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.4.5.3. Japan Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.4.6.2. India Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.4.6.3. India Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.4.7.2. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.4.7.3. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.5.2. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.5.3. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.5.4.2. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.5.4.3. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.5.5.2. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.5.5.3. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Oracle Corporation
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. ArisGlobal LLC
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. AB Cube
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Max Delivery
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Relsys
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Sparta Systems, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. United BioSource Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. EXTEDO GmbH
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Ennov Solutions, Inc.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Umbra Global
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

List of Figures

1. Market research process
2. Market research methodology
3. Global Pharmacovigilance and Drug Safety Software Market revenue, 2017–2025 (USD Million)
4. Porter’s Five Forces analysis
5. Pharmacovigilance and Drug Safety Software Market by Functionality 
6. Pharmacovigilance and Drug Safety Software by Delivery Mode
7. Pharmacovigilance and Drug Safety Software by end-user
8. Pharmacovigilance and Drug Safety Software by region
9. Company market share analysis, 2018
10. Global Pharmacovigilance and Drug Safety Software Market revenue share by Functionality, 2017 and 2025
11. Global ADR Reporting Software Market, 2017–2025 (USD Million)
12. Global Drug Safety Audits Software market, 2017–2025 (USD Million)
13. Global Issue Tracking Software market, 2017–2025 (USD Million)
14. Global Fully Integrated Software market, 2017–2025 (USD Million)
15. Global Pharmacovigilance and Drug Safety Software Market revenue share by Delivery Mode, 2017 and 2025
16. Global Pharmacovigilance and Drug Safety Software Market for On-premises, 2017–2025 (USD Million)
17. Global Pharmacovigilance and Drug Safety Software Market for On-demand, 2017–2025 (USD Million)
18. Global Pharmacovigilance and Drug Safety Software Market revenue share by end-user, 2017 and 2025
19. Global Pharmacovigilance and Drug Safety Software Market for pharma and biotech companies, 2017–2025 (USD Million)
20. Global Pharmacovigilance and Drug Safety Software Market for Contract Research Organizations, 2017–2025 (USD Million)
21. Global Pharmacovigilance and Drug Safety Software Market for Business Process Outsourcing, 2017–2025 (USD Million)
22. Global Pharmacovigilance and Drug Safety Software Market for Other Pharmacovigilance Service Providers, 2017–2025 (USD Million)


List of Tables

1. Pharmacovigilance and Drug Safety Software Market: Market Snapshot                                                                                    
2. Drivers of global Pharmacovigilance and Drug Safety Software Market: Impact analysis 
3. Restraints of global Pharmacovigilance and Drug Safety Software Market: Impact analysis  
4. North America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
5. North America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
6. North America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million) 
7. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
8. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
9. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
10. Canada Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
11. Canada Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
12. Canada Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
13. Europe Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
14. Europe Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
15. Europe Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
16. UK Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
17. UK Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
18. UK Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
19. Germany Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
20. Germany Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
21. Germany Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
22. France Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
23. France Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
24. France Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
25. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
26. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
27. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
28. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
29. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
30. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
31. China Pharmacovigilance and Drug Safety Software Market revenue, by Functionality2017–2025 (USD Million) 
32. China Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode2017–2025 (USD Million) 
33. China Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
34. Japan Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
35. Japan Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
36. Japan Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
37. India Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
38. India Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
39. India Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
40. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
41. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
42. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
43. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
44. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
45. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
46. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
47. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
48. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
49. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
50. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
51. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
52. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
53. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
54. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)

Methodology

Free Analysis

The scope and definition of pharmacovigilance have evolved to identify the significance of a systems approach for improving and monitoring the harmless and safe use of medicines. According to the World Health Organization (WHO), pharmacovigilance is the science and activities related to the understanding, evaluation, detection, and prevention of adversarial reactions to medications or problems related to medicine. This pharmacovigilance software is majorly used by biotech and pharmaceutical organizations, business process outsourcing firms (BPOs), contract research organizations (CROs), and many other pharmacovigilance service providers.

Pharmacovigilance globalization with extensive availability and access of the internet is likely to fuel the global pharmacovigilance and drug safety software market in the future. Moreover, the rising health information functionality will further support the adoption and usage of pharmacovigilance software over the estimated period, as it reduces medical expenditures and improves patient health. The augmenting adoption of pharmacovigilance software by numerous outsourcing companies will also serve as a huge growth opportunity for the global pharmacovigilance and drug safety software market over the forecast timespan. In contrast, government bodies comprising EMEA and FDA have increased the pressure on pharmaceutical and biotechnology companies for manufacturing safe drugs.

Global Pharmacovigilance and Drug Safety Software Market

The global pharmacovigilance and drug safety software market is segmented on the basis of functionality, delivery mode, and end-user. Based on functionality, the market is segmented into drug safety audits software, ADR reporting software, fully integrated software, and issue tracking software. The fully integrated software segment is expected to register the highest growth over the forecast time period, owing to the increasing need to prevent errors in database management regarding medicines.

By delivery mode, the market is segmented into on-premises and on-demand. The on-premises segment is anticipated to hold the largest market share, whereas, the on-demand segment is expected to register the highest CAGR over the estimated time period. By end-user, the market is segmented into contract research organizations (CROS), business process outsourcing (BPO) firms, pharma and biotech companies, and other pharmacovigilance service providers.

By region, North America is anticipated to lead the global pharmacovigilance and drug safety software market over the forecast period, owing to the high adoption of pharmacovigilance and drug safety software and favorable government regulations. Europe was the second largest market in 2018, followed by the Asia Pacific. The Asia Pacific pharmacovigilance and drug safety software market is anticipated to record lucrative growth over the projected time period, subject to an increasing number of clinical trials being conducted in the region and the considerable cost-saving benefits.

Some key players of the global pharmacovigilance and drug safety software market include Oracle Corporation, ArisGlobal LLC, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH, and Ennov Solutions, Inc., among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed